Ahsan Amjad

Ahsan Amjad serves as Co-Founder and CEO of ABC Labs, where an impactful project established the largest pandemic lab in Sweden, achieving approximately 25% of the national capacity, nine publications, and around 180 million USD in revenues, while currently focusing on automated substance abuse screening in workplaces. Ahsan is the Founder of RFB Orient, which is a privately owned portfolio of health innovations. Ahsan also holds board member and investor roles in several organizations, including KRY, which leads as Europe's digital-first healthcare provider with over 10 million patient appointments, and ImagineCare, a care management platform now collaborating with the Swedish public healthcare system. Additional board memberships include Geras Solutions, specializing in cognitive disease prevention and diagnosis, and HerCare Kvinnoklinik, focussing on women's health and hormone replacement therapies. Previous experience includes Co-Founder and CEO of Immune Therapy Holdings and Director of the Indonesia International Institute for Life-Sciences.